Nathan Connell: Bleeding Risk Is Not Limited to Delivery
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared a post on Linkedln about a recent article published in Haemophilia Journal, co-authored by him and his colleagues, adding:
“Just published in Haemophilia Journal in conjunction with the World Federation of Hemophilia 2026 Congress in Kuala Lumpur, Malaysia: ‘Obstetric and Gynaecologic Considerations in Inherited Bleeding Disorders.’
Women and girls with inherited bleeding disorders have too often been under-recognized, under-diagnosed, and under-served.
This review highlights that bleeding risk is not limited to delivery.
It spans the reproductive lifespan, from heavy menstrual bleeding and iron deficiency, to fertility treatment, prenatal diagnosis, pregnancy planning, neuraxial anesthesia decisions, mode of delivery, and both primary and secondary postpartum hemorrhage.
A central message of the paper is that care must be proactive, multidisciplinary, and individualized.
For many patients, better outcomes depend on earlier recognition of bleeding symptoms, coordinated care across hematology, obstetrics, gynecology, anesthesia, and genetics, and thoughtful delivery planning well before labor.
The review also underscores how advances in preconception counseling, prenatal testing, and carrier evaluation are reshaping reproductive choice and risk assessment.
This is also a call to move beyond the historical framing of women only as ‘carriers’ and toward a model that recognizes their own bleeding phenotype, health risks, and need for lifelong care.
Grateful to my coauthors Joanna Davies, Rezan Abdul-Kadir, and Zane Kaplan for their partnership on this work.”
Title: Obstetric and Gynaecologic Considerations in Inherited Bleeding Disorders
Authors: Nathan T. Connell, Joanna Davies, Rezan Abdul-Kadir, Zane Kaplan
Other posts featuring Nathan Connell on Hemostasis Today.
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn Ruksakulpiwat։ A New Milestone in the Development of the Stroke Risk Screening Scales